Verona Pharma plc (NASDAQ:VRNA) Receives $66.83 Consensus Price Target from Brokerages
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
